{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:09:23Z","timestamp":1777860563786,"version":"3.51.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Beh\u00e7et\u2019s disease (BD) is an autoimmune disease presented with recurrent oral aphthous ulcers, genital ulcers, uveitis and skin lesions. The cutaneous manifestations are often refractory and more resistant to conventional therapy. This report provides a new treatment of low-dose interleukin-2 (IL-2) with refractory BD patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 37-year-old female patient experienced oral ulcer and erythema nodosum on the right leg for over 12 months and resisted to Methylprednisolone and Thalidomide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient suffered from recurrent painful oral ulceration and an erythema nodosum. Pathergy test is also positive. Thus, we diagnosed her as BD according to the International Criteria for Beh\u00e7et\u2019s Disease (ICBD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient took Methylprednisolone 8\u2009mg qd, Thalidomide 50\u2009mg qn and Hydroxychloroquine 200\u2009mg bid successively as treatment. However, the medicine didn\u2019t take effect. Finally, this patient was given low-dose IL-2 intramuscular injection qod for 3 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Oral ulcers and the erythema disappeared and the patient has been symptom-free for 6 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>low-dose IL-2 is a safe and effective treatment for refractory BD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031173","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:01:36Z","timestamp":1666638096000},"page":"e31173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Refractory Beh\u00e7et\u2019s disease treated with low-dose interleukin-2: A case report"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-6603","authenticated-orcid":false,"given":"Wenyan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Rheumatology & Immunology, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Immunology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Immunology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Immunology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.304.6836.1199","article-title":"Beh\u00e7et\u2019s disease.","volume":"304","author":"Wechsler","year":"1992","journal-title":"BMJ"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1148\/rg.e31","article-title":"Radiologic and clinical findings of Beh\u00e7et disease: comprehensive review of multisystemic involvement.","volume":"28","author":"Chae","year":"2008","journal-title":"Radiographics"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s disease: an overview of etiopathogenesis.","volume":"10","author":"Leccese","year":"2019","journal-title":"Front Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"590622","DOI":"10.3389\/fimmu.2020.590622","article-title":"Neutrophil extracellular traps promote aberrant macrophages activation in Beh\u00e7et\u2019s disease.","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.04.008","article-title":"Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet\u2019s disease.","volume":"235","author":"Gelmez","year":"2021","journal-title":"Immunol Lett"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.clindermatol.2017.06.004","article-title":"Beh\u00e7et disease: new aspects.","volume":"35","author":"Bulur","year":"2017","journal-title":"Clin Dermatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"746","DOI":"10.55563\/clinexprheumatol\/lnn76t","article-title":"Low-dose IL-2 effectively restored decreased regulatory T cells in patients with Beh\u00e7et\u2019s disease.","volume":"39","author":"Liu","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"A collaborative study of 27 countries on the sensitivity and specificity of the new criteria.","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-021-00301-1","article-title":"Beh\u00e7et syndrome.","volume":"7","author":"Yazici","year":"2021","journal-title":"Nat Rev Dis Primers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:21Z","timestamp":1746333681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":10,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031173","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}